Ultrasound FPP, in Visit Clinic

FPP in ultrasound commonly stands for "fetal pole present" (fetal pole positive). It indicates an early embryo is visible within the gestational sac, often alongside cardiac activity and crown–rump length. Reporting FPP helps confirm an intrauterine pregnancy, estimate gestational age, and assess early viability; follow-up scans or clinical correlation guide next steps if findings are equivocal.

FPP stands for Finished Pharmaceutical Product. It refers to the final medicinal product in its marketed dosage form—tablets, capsules, injectables, creams—ready for packaging, labeling, distribution and patient use. An FPP contains the active pharmaceutical ingredient(s) formulated with excipients and must meet established quality, safety, stability, and regulatory specifications before release to the market.

The ultrasound for the fetal anomaly (FPP) scan is a detailed mid‑pregnancy (usually 18–22 weeks) sonogram to examine fetal anatomy and growth. It assesses the brain, spine, heart, face, abdomen, kidneys, limbs, placenta position and amniotic fluid, and screens for structural abnormalities. It’s non‑invasive, typically transabdominal, takes 20–45 minutes, and may prompt follow‑up if abnormal findings appear.

In medical and public-health contexts, FPP commonly stands for "Family Planning Programme" (or "Program") — organized services providing contraception, preconception counseling, pregnancy planning, reproductive health education, and related clinical care. FPP can have other specialty‑specific meanings in clinical records or research, so confirm the intended expansion from the surrounding context or the issuing organization.

An FPP NT scan is an early pregnancy ultrasound that assesses the fetal profile (FPP) and measures nuchal translucency (NT). Performed at about 11–13+6 weeks, it helps confirm viability, estimate gestational age, detect major structural issues, and screen for chromosomal conditions such as Down syndrome. It’s noninvasive and often combined with maternal blood tests for risk assessment.

Fetal sex is usually identified by ultrasound during the mid-pregnancy anatomy scan (about 18–20 weeks). Earlier (11–14 weeks) skilled sonographers can sometimes use the genital “nub” angle, but accuracy is lower. In the second trimester the sonographer looks for a penis/scrotum or labial folds. Accuracy depends on gestational age, fetal position, equipment and operator skill; results aren’t 100% certain.